Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy

AIM: To compare capecitabine and oxaliplatin (XELOX) with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy. METHODS: Clinical data from 206 patients who received XELOX or S-1 regimens as adjuvant chemotherapy in stage III gastric cancer were collected. Patients were divi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Jang Ho, Lim, Jae Yun, Cho, Jae Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645114/
https://www.ncbi.nlm.nih.gov/pubmed/29040299
http://dx.doi.org/10.1371/journal.pone.0186362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645114/
https://www.ncbi.nlm.nih.gov/pubmed/29040299
http://dx.doi.org/10.1371/journal.pone.0186362

Ejemplares similares